Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Vedanta Biosciences is raising $16,570,052.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Bernat Olle played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vedanta Biosciences

Vedanta is developing a novel class of therapies that modulate pathways of interaction between the human microbiome and the host immune system. Vedanta was co-founded by PureTech Health and a group of world renowned experts in immunology and microbiology.

To learn more about Vedanta Biosciences, visit http://www.vedantabio.com/

Contact:
Bernat Olle, Chief Executive Officer
857-706-1427
bolle@vedantabio.com
https://www.linkedin.com/in/bernat/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved